✦ LIBER ✦

Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes

✍ Scribed by Skrumsager, B. K.; Nielsen, K. K.; Müller, M.; Pabst, G.; Drake, P. G.; Edsberg, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, Safety, and Tolerabili

✍ Jani, Rajendra H.; Kansagra, Kevinkumar; Jain, Mukul R.; Patel, Harilal 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 582 KB

Safety, tolerability, pharmacokinetics a

✍ Seino, Yutaka; Nakajima, Hiromu; Miyahara, Hajime; Kurita, Takashi; Bush, Mark A 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 230 KB

Effects of peroxisome proliferator-activ

✍ M. Bajaj; S. Suraamornkul; L. J. Hardies; L. Glass; N. Musi; R. A. DeFronzo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 195 KB

A Multiple-Ascending-Dose Study to Evalu

✍ Leifke, E; Naik, H; Wu, J; Viswanathan, P; DeManno, D; Kipnes, M; Vakilynejad, M 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 324 KB

Pharmacokinetics, Pharmacodynamics, and

✍ Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

The effect of dual PPAR α/γ stimulation

✍ Selcuk Seber; Sema Ucak; Okcan Basat; Yuksel Altuntas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB